According to OncoCyte 's latest financial reports the company's current earnings are A$0.7 Million. In 2023 the company made an earning of -A$39.52 Million a decrease over its 2022 earnings that were of A$4.32 Million. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -A$63.76 Million | 61.32% |
2023 | -A$39.52 Million | -1014.8% |
2022 | A$4.32 M | -103.7% |
2021 | -A$0.12 Billion | 135.23% |
2020 | -A$49.59 Million | 39.06% |
2019 | -A$35.66 Million | 42.35% |
2018 | -A$25.05 Million | -18.68% |
2017 | -A$30.81 Million | 73.46% |
2016 | -A$17.76 Million | 27.86% |
2015 | -A$13.89 Million |